CEPS

Cantor Equity Partners VI, Inc. Class A Ordinary Shares

There isn't enough reported data to score CEPS yet.

MS

Morgan Stanley

62
Fundamentals71/ 100
Valuation48/ 100
Upside potential73/ 100
Risk potential11/ 100

MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.

CEPS Fundamentals

MetricStatus
Unavailable
Healthy
N/A
N/A

CEPS's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like CEPS.

MS Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.

CEPS PE Valuation

LevelPEPriceVs current
Cheap120x$9.62-5.4%
Current120x$10.17—
Fair122x$9.78-3.8%
Expensive417x$33.37+228%

Historical ranges are pointers, not guarantees.

CEPS has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.

MS PE Valuation

CHEAPFAIREXPENSIVE5.5x11x17x22x
CHEAPFAIREXPENSIVE5.5x11x17x22x
LevelPEPriceVs current
Cheap11x$134-29%
Fair14x$178-5.7%
Forward14x$189—
Current15x$189—
Expensive18x$223+18%

Historical ranges are pointers, not guarantees.

MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.

CEPS Forward outlook

There aren't enough analyst estimates for CEPS to show an outlook.

MS Forward outlook

MetricOutlook
Improving
Growth
Growth
Improving
Limited
Moderate

Analysts expect earnings and revenue growth for MS, with profitability improving.

CEPS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.17 on Nov 12.

There is not enough scenario data to compare CEPS and MS's risk to reward.

MS Risk to reward

ScenarioChangePrice
Upside+29%$243.85
Downside-11%$168.44

Calculated from the latest close: $189.17 on Nov 12.

There is not enough scenario data to compare CEPS and MS's risk to reward.

CEPS Earnings Per Share

Q1 2026: $0.02Q2 2026: $0.08
Q1 2026: $0.02Q2 2026: $0.08

CEPS and MS do not have enough comparable growth data to identify a winner.

MS Earnings Per Share

Q4 2023: $5.18Q1 2024: $5.50Q2 2024: $6.08Q3 2024: $6.58Q4 2024: $7.95Q1 2025: $8.53Q2 2025: $8.84Q3 2025: $9.76Q4 2025: $10.21Q1 2026: $11.04Q2 2026: $12.37Q3 2026: $12.60Forward: $13.39
Q4 2023: $5.18Q1 2024: $5.50Q2 2024: $6.08Q3 2024: $6.58Q4 2024: $7.95Q1 2025: $8.53Q2 2025: $8.84Q3 2025: $9.76Q4 2025: $10.21Q1 2026: $11.04Q2 2026: $12.37Q3 2026: $12.60Forward: $13.39
QuarterTTM EPSYoY
Forward$13.39+6.3%
Q3 2026$12.60+29%
Q2 2026$12.37+40%
Q1 2026$11.04+29%
Q4 2025$10.21+28%
Q3 2025$9.76+48%
Q2 2025$8.84+45%
Q1 2025$8.53+55%
Q4 2024$7.95+53%

MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.

CEPS Quarterly Revenue

Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0

CEPS and MS do not have enough comparable growth data to identify a winner.

MS Quarterly Revenue

Q4 2023: $12.9BQ1 2024: $15.1BQ2 2024: $15BQ3 2024: $15.4BQ4 2024: $16.2BQ1 2025: $17.7BQ2 2025: $16.8BQ3 2025: $18.2BQ4 2025: $17.9BQ1 2026: $20.6BQ2 2026: $21.3BQ3 2026: $20.3B
Q4 2023: $12.9BQ1 2024: $15.1BQ2 2024: $15BQ3 2024: $15.4BQ4 2024: $16.2BQ1 2025: $17.7BQ2 2025: $16.8BQ3 2025: $18.2BQ4 2025: $17.9BQ1 2026: $20.6BQ2 2026: $21.3BQ3 2026: $20.3B
QuarterRevenueYoY
Q3 2026$20.3B+12%
Q2 2026$21.3B+27%
Q1 2026$20.6B+16%
Q4 2025$17.9B+10%
Q3 2025$18.2B+18%
Q2 2025$16.8B+12%
Q1 2025$17.7B+17%
Q4 2024$16.2B+26%

MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.

CEPS Free Cash Flow

Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: $17,700Q2 2026: −$4
Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: $17,700Q2 2026: −$4

CEPS and MS do not have enough comparable growth data to identify a winner.

MS Free Cash Flow

Q4 2023: −$17.8BQ1 2024: $4.4BQ2 2024: $2.5BQ3 2024: −$17.3BQ4 2024: $11.8BQ1 2025: −$24BQ2 2025: $11.8BQ3 2025: −$3.3BQ4 2025: −$2.4BQ1 2026: −$7.1BQ2 2026: −$2.7BQ3 2026: −$46B
Q4 2023: −$17.8BQ1 2024: $4.4BQ2 2024: $2.5BQ3 2024: −$17.3BQ4 2024: $11.8BQ1 2025: −$24BQ2 2025: $11.8BQ3 2025: −$3.3BQ4 2025: −$2.4BQ1 2026: −$7.1BQ2 2026: −$2.7BQ3 2026: −$46B
QuarterFree cash flowYoY
Q3 2026-$46B-$42.7B
Q2 2026-$2.7B-123%
Q1 2026-$7.1B+$16.9B
Q4 2025-$2.4B-120%
Q3 2025-$3.3B+$14B
Q2 2025$11.8B+368%
Q1 2025-$24B-650%
Q4 2024$11.8B+$29.6B

MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.

CEPS Total Shares

Q2 2025: 13MQ3 2025: 13MQ4 2025: 15MQ1 2026: 15MQ2 2026: 15M
Q2 2025: 13MQ3 2025: 13MQ4 2025: 15MQ1 2026: 15MQ2 2026: 15M
PeriodChange %Net change
Quarterly0%--
1 year+15%+1.9M shares

CEPS has 15M diluted shares, up 15% from a year ago.

MS Total Shares

Q4 2023: 1.6BQ1 2024: 1.6BQ2 2024: 1.6BQ3 2024: 1.6BQ4 2024: 1.6BQ1 2025: 1.6BQ2 2025: 1.6BQ3 2025: 1.6BQ4 2025: 1.6BQ1 2026: 1.6BQ2 2026: 1.6BQ3 2026: 1.6B
Q4 2023: 1.6BQ1 2024: 1.6BQ2 2024: 1.6BQ3 2024: 1.6BQ4 2024: 1.6BQ1 2025: 1.6BQ2 2025: 1.6BQ3 2025: 1.6BQ4 2025: 1.6BQ1 2026: 1.6BQ2 2026: 1.6BQ3 2026: 1.6B
PeriodChange %Net change
Quarterly-0.2%-3M shares
1 year-1.5%-24M shares
3 years-4.7%-77M shares
5 years-14%-246M shares
Available history-4.5%-74M shares

MS has the edge over CEPS on shareholder dilution, with a more favorable share count trend.

CEPS Net Leverage

MS Net Leverage

Q4 2023: 10.7xQ1 2024: 9.8xQ2 2024: 9.8xQ3 2024: 10.2xQ4 2024: 7.9xQ1 2025: 8.7xQ2 2025: 8.7xQ3 2025: 8.4xQ4 2025: 8.6xQ1 2026: 8.2xQ2 2026: 7.3xQ3 2026: 7.8x
Q4 2023: 10.7xQ1 2024: 9.8xQ2 2024: 9.8xQ3 2024: 10.2xQ4 2024: 7.9xQ1 2025: 8.7xQ2 2025: 8.7xQ3 2025: 8.4xQ4 2025: 8.6xQ1 2026: 8.2xQ2 2026: 7.3xQ3 2026: 7.8x
QuarterNet LeverageStatus
Q3 20267.8xHigh
Q2 20267.3xHigh
Q1 20268.2xHigh
Q4 20258.6xHigh
Q3 20258.4xHigh
Q2 20258.7xHigh
Q1 20258.7xHigh
Q4 20247.9xHigh

MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.

CEPS Weekly Momentum

MetricValueStatus
RSI40.4Neutral
Stochastic20.0Neutral

CEPS's weekly RSI is 40 (neutral) and its Stochastic is 20 (neutral).

MS Weekly Momentum

MetricValueStatus
RSI45.0Neutral
Stochastic18.7Oversold

MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).

CEPS PE vs Financial Services Sector

MetricCEPSSector medianRelative
PE120x13x824% above

CEPS is trading at 120x earnings, a 824% premium to the Financial Services sector's median of 13x, though its earnings don't support one.

MS PE vs Financial Services Sector

MetricMSSector medianRelative
PE15x13x15% above
PE %59634 pts below

MS has the edge over CEPS on valuation relative to its sector.

CEPS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.20.2% below
20 week MA$10.31.3% below

MS has stronger trend alignment. CEPS is above 0 of 2 weekly averages versus MS above 3 of 5.

MS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$186.51.5% above
20 week MA$203.36.9% below
50 week MA$191.91.4% below
100 week MA$164.915% above
200 week MA$129.346% above

MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.

CEPS Yearly ROI

YearStart priceEnd priceROI
2026 YTD$10.2$10.2+0.2%

It's roughly flat so far in 2026.

MS Yearly ROI

YearStart priceEnd priceROI
2020$51.1$68.1+33%
2021$68.1$99.3+46%
2022$99.3$86.1-13%
2023$86.1$93.3+8.3%
2024$93.3$126.8+36%
2025$126.8$181.9+43%
2026 YTD$181.9$189.2+4%

MS has the edge over CEPS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key